Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000846426) titled 'A healthy volunteer study to check the effect and safety of PTC844 tablets with standard meal in multiple ascending doses across the period of 14 days followed by a study of single ascending dose in the participants' on Aug. 6.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: CTI Clinical Trial and Consulting Services Australia Pty Limited
Condition:
Immunological Disorders
Immunological Disorders
Inflammatory and Immune System - Autoimmune diseases
Inf...